Evidence map›Paper›PMID 29678902›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.

Shengfeng Wang, Temidayo Ogundiran, Adeyinka Ademola, Oluwasola A Olayiwola, Adewunmi Adeoye, Adenike Sofoluwe, Imran Morhason-Bello, Stella Odedina, Imaria Agwai, Clement Adebamowo and 4 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Observational
  8. The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  9. Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  10. Article
  11. A Validated Risk Prediction Model for Breast Cancer in US Black Women.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shengfeng WangCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
Temidayo OgundiranDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0001-6405-2131
Adeyinka AdemolaDepartment of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Oluwasola A OlayiwolaDepartment of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adewunmi AdeoyeDepartment of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adenike SofoluweDepartment of Radiology, University College Hospital, Ibadan, Nigeria.
Imran Morhason-BelloCenter for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria.
Stella OdedinaCenter for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria.ORCID 0000-0002-6259-6773
Imaria AgwaiCenter for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria.
Clement AdebamowoDepartment of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, Maryland.ORCID 0000-0002-6571-2880
Millicent ObajimiDepartment of Radiology, University College Hospital, Ibadan, Nigeria.
Oladosu OjengbedeCenter for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Ibadan, Nigeria.
Olufunmilayo I OlopadeCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois. dhuo@health.bsd.uchicago.edu folopade@medicine.bsd.uchicago.edu.
Dezheng HuoCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois. dhuo@health.bsd.uchicago.edu folopade@medicine.bsd.uchicago.edu.

Funding

Variation in Hormone and xenobiotic metabolizing enzyme genes and breast cancerP50CA125183 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S. · 2006 to 2010
$11.3M
Developing an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6M
Using Genomics to Reduce Breast Cancer Disparities in the African DiasporaU01CA161032 · NCI · UNIVERSITY OF CHICAGO · PI HUO, DEZHENG, OLOPADE, OLUFUNMILAYO F. · 2012 to 2015
$3.6M
Genetics of Breast Cancer in BlacksR01CA089085 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F. · 2002 to 2006
$2.8M
International Partnership for Interdisciplinary Research TrainingD43TW009112 · FIC · UNIVERSITY OF CHICAGO · PI OLOPADE, CHRISTOPHER O, OLOPADE, OLUFUNMILAYO F. · 2012 to 2016
$1.1M
FIC NIH HHS D43 TW009112NCI NIH HHS K12 CA139160NCI NIH HHS P50 CA125183NCI NIH HHS R01 CA089085NCI NIH HHS U01 CA161032
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCase-Control StudiesFemaleHumansModels, StatisticalNigeriaRisk FactorsWomen's Health

Identifiers

PMID29678902
PMCPMC6086588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.